Pilot and Feasibility Study for the Treatment of Pre-diabetes in Patients With Cystic Fibrosis.
Phase of Trial: Phase II
Latest Information Update: 08 Jun 2017
At a glance
- Drugs Repaglinide (Primary)
- Indications Glucose intolerance
- Focus Adverse reactions
- 01 Jan 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 12 Mar 2010 New trial record